Cardinal Points FZCO To Drive Growth In Pharma, Agrochemical Sectors Globally

Cardinal Points FZCO, a Dubai-based venture, today announced an ambitious strategy to accelerate innovation in the pharmaceutical and agrochemical industries, both in India and globally. With a strong commitment to supporting groundbreaking projects, the company has initiated funding to advance select programs at premier centers in India known for their exceptional service quality and global accreditations.

Cardinal Points FZCO To Drive Growth In Pharma, Agrochemical Sectors Globally

Esteemed investment banker, Rajat Tiwari, who spearheaded the funding round, highlighted India’s unique advantages for cost-effective development. “During our due diligence, we met with leading scientists worldwide who have patents and inventions, yet face prohibitive development costs in their regions. India provides a remarkable opportunity. With the right partners, funding, and management, global projects can be realized here, benefiting all stakeholders,” he stated. Cardinal Points has chosen Dr. Akash Mathur as a key partner, citing his expertise and successful track record in executing cost-effective, timely development of international programs.

Dr. Mathur expressed his enthusiasm: “This opportunity delivers a substantial reduction in development time, which in turn preserves the usable patent life. India is a recognized leader in the global generics market, and we’re now leveraging this strength for patented projects. Indian scientists and the IP landscape are well-equipped to handle such high-stakes development.”

Founders Anil Sharma and Shailendra Saxena commented, “We are thrilled to launch Cardinal Points FZCO by funding cutting-edge programs in diagnostics, agrochemicals, and Phase III development of select pharmaceuticals. Our vision is to create a pathway that benefits all involved—from researchers to end-users worldwide.”

Tiwari also shared future funding plans: “We’ve raised approximately USD 10 million for initial seed investments and aim to secure an additional USD 50 million in Series A funding. With this momentum, we anticipate several listing opportunities for our funded projects in the near future.”

Cardinal Points FZCO is positioned to make a substantial impact on the global healthcare and agriculture industries, driving both innovation and accessibility through strategic investment in India’s robust R&D ecosystem.

Also read: HEALTHCARE GOVERNANCE AND COMPLIANCE: ESSENTIAL LEGAL FRAMEWORKS FOR OPERATIONAL INTEGRITY IN INDIA